For a second year in a row, Becker's Hospital Review has selected Ascension’s Ascension Via Christi St. Francis for its annual list of 100 hospital and health systems with great oncology programs.
Hospitals and health systems were chosen based on their rankings, designations and outstanding achievement awards such as the U.S. News & World Report cancer care rankings, CareChex cancer care rankings, BlueCross BlueShield Association Blue Distinction Cancer designation, National Cancer Institute designations and American College of Surgeons Commission on Cancer accreditation and awards.
Via Christi is the only Kansas hospital outside the Kansas City metro area to make Becker’s 2017 list of hospitals known for their innovation and expertise in treating cancer patients.
“According to the American Cancer Society, there are 4,630 new cancer cases diagnosed and 1,650 cancer-related deaths every day, highlighting the importance of superior oncology programs at the local, regional and national level,” according to Becker’s. “Many of the hospitals and health systems included on this list incorporate the latest technology to improve outcomes into their programs, while also ensuring a superior patient experience.”
Shaker Dakhil, MD, the Cancer Center of Kansas oncologist who serves as Via Christi’s medical director of Oncology Services, said he was pleased, but not surprised, by the Becker’s recognition.
“Over the years, Via Christi has shown tremendous commitment to cancer care in developing great outreach programs, inpatient services, clinical research and synergy with the physicians who serve as the backbone of the program,” said Dakhil, whose CCK colleague, Pavan Reddy, MD, serves as co-medical director for Via Christi’s Cancer Outreach and Risk Assessment program together with Ascension Medical Group’s Patty Tenofsky, MD.
Bassam Mattar, MD, also of CCK, serves as medical director for Via Christi’s bone marrow transplant program and Brett Grizzell, MD, a cardiothoracic surgeon with Wichita Surgical Specialists, serves as medical director for the lung cancer screening program Via Christi launched last year.
“This recognition by Becker’s is a wonderful testament to the dedication of these and other physicians who partner with our bedside clinicians to provide the best possible care with compassion and dignity,” said Claudio Ferraro, the Via Christi executive responsible for Oncology Services. “It also recognizes Via Christi’s decades of investment in the resources needed to develop a comprehensive, integrated system of care for those battling cancer.”
Via Christi was the area’s first and for many years only hospital accredited by the American College of Surgeons Commission on Cancer. First accredited by the Foundation for Accreditation for Cellular Therapy, it continues to be the area’s only hospital accredited for bone marrow transplantation.
It also is home to an NCI-Community Oncology Research Program, one of the nation’s leading sites for clinical research.
“It truly takes a team to provide outstanding cancer care and we’re blessed to have a great one,” said Keisha Humphries, who serves as administrator for Oncology Services at Via Christi and the NCORP program.